CAS NO: | 2616704-22-2 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A iscleavablethrough pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
分子量 | 1062.21 | ||||||||||||||||
性状 | Oil | ||||||||||||||||
Formula | C50H79N9O16 | ||||||||||||||||
CAS 号 | 2616704-22-2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 200 mg/mL(188.29 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |